Scientific Articles Animal Models

153.
Siwy J, Zoja C, Klein J, Benigni A, Mullen W, Mayer B, Mischak H, Jankowski J, Stevens R, Vlahou A, Kossida S, Perco P, Bahlmann FH.
Evaluation of the Zucker Diabetic Fatty (ZDF) Rat as a Model for Human Disease Based on Urinary Peptidomic Profiles.
PLoS One. 2012;7(12):e51334. doi: 10.1371/journal.pone.0051334. Epub 2012 Dec 7. 

View AbstractDownload     Request Reprint

 

138.
von zur Muhlen C, Schiffer E, Sackmann C, Zürbig P, Neudorfer I, Zirlik A, Htun N, Iphöfer A, Jänsch L, Mischak H, Bode C, Chen YC, Peter K
Urine proteome analysis reflects atherosclerotic disease in an ApoE-/- mouse model and allows the discovery of new biomarkers in mouse and human atherosclerosis
Mol Cell Proteomics. 2012 Jul;11(7):M111.013847. Epub 2012 Feb 27.
         
View AbstractDownload     Request Reprint

 

137.
Rouse R, Siwy J, Mullen W, Mischak H, Metzger J, Hanig J
Proteomic Candidate Biomarkers of Drug-Induced Nephrotoxicity in the Rat
PLoS ONE. 2012;7(4): e34606
         
View AbstractDownload     Request Reprint

 
 

88.
Mischak H, Espandiari P, Sadrieh N, Hanig J
Profiling of rat urinary proteomic patterns associated with drug-induced nephrotoxicity using capillary electrophoresis coupled with mass spectrometry as a potential model for detection of drug-induced adverse effects
PROTEOMICS - Clinical Applications 2009; 9:1062-1071.
         
View Publisher Website      Request Reprint   

 
 

41.
Frommberger M, Zürbig P, Jantos J, Krahn T, Mischak H, Pich A, Just I, Schmitt-Kopplin P, Schiffer E
Peptidomic analysis of rat urine using capillary electrophoresis coupled to mass spectrometry
PROTEOMICS - Clinical Applications 2007, 1: 650-660
         
View Abstract      Request Reprint